Miromatrix Medical, Inc. operates as a biotechnology company, which engages in the development of biological human organs to solve the chronic shortage of transplantable organs. It offers perfusion decellularization and recellularization technology, as well as organ-derived biological products such as MIROMESH and MIRODERM for soft tissue reinforcement and advanced wound care. The company was founded in 2009 by Doris A. Taylor and Cohen Robert and is headquartered in Eden Prairie, MN.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Miromatrix Medical Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Miromatrix Medical Inc market cap is $92.95M.
What is the 52-week high for Miromatrix Medical Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Miromatrix Medical Inc 52 week high is $3.73 as of October 25, 2025.
What is the 52-week low for Miromatrix Medical Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Miromatrix Medical Inc 52 week low is $0.9065 as of October 25, 2025.
What is the PE ratio of Miromatrix Medical Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Miromatrix Medical Inc’s P/E ratio is -2.97.
What is the Price-to-Book ratio of Miromatrix Medical Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Miromatrix Medical Inc P/B ratio is 5.9805.
What is Miromatrix Medical Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Miromatrix Medical Inc's EBITDA is -0.81.
What is the 50-day moving average of Miromatrix Medical Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Miromatrix Medical Inc 50-day moving average is $2.87.
